Keratoacanthoma formation after skin grafting: A brief report and pathophysiological hypothesis.
Keratoacanthoma formation after skin grafting is rare. We report the third case in the literature of multiple keratoacanthomas developed at both split-thickness skin graft donor and recipient sites. We provide possible explanations for this poorly understood phenomenon and highlight its implications on treatment options.
Monash University, Melbourne, Victoria, Australia.
Senhong
S
Lee
Wellington Hospital Capital Coast District Health Board, Wellington, New Zealand.|Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.
Ian
I
Coutts
Histolab, Melbourne, Victoria, Australia.
Andrew
A
Ryan
Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.|The Alfred Hospital, Alfred Health, Melbourne, Victoria, Australia.
Anastasios
A
Stavrakoglou
D017255:Acitretin / Q000627:therapeutic use; D000369:Aged, 80 and over; D003475:Curettage; D005260:Female; D006801:Humans; D007636:Keratoacanthoma / Q000209:etiology* / Q000473:pathology / Q000628:therapy*; D007641:Keratolytic Agents / Q000627:therapeutic use; D016038:Skin Transplantation / Q000009:adverse effects*; D060053:Transplant Donor Site / Q000473:pathology
D007641:Keratolytic Agents; D017255:Acitretin
Koebner phenomenon; keratoacanthoma; skin graft